结节病患者的硬脑膜边缘区淋巴瘤
本文报告一例60岁有结节病病史的男性发生硬脑膜边缘区B细胞淋巴瘤,符合结节病-淋巴瘤综合征;肿瘤手术切除后病理确诊,分期为局限性疾病,接受局部放疗控制软脑膜病变;作者建议结节病患者硬脑膜占位应将淋巴瘤列为重要鉴别诊断。
要点
- 结节病患者硬脑膜占位应将淋巴瘤列入鉴别诊断。
- 本例为60岁男性结节病患者,硬脑膜肿瘤手术切除后病理为边缘区B细胞淋巴瘤。
- 分期确认局限性疾病后接受局部放疗控制软脑膜病变。
核心结论
- 鉴于结节病与淋巴瘤的关联,作者建议结节病患者硬脑膜占位性病变应将淋巴瘤列为重要鉴别诊断之一。
研究设计与样本
- 个案报告:一例60岁有结节病病史的男性硬脑膜淋巴瘤病例。
主要发现
- 硬脑膜肿瘤手术切除,病理检查示边缘区B细胞淋巴瘤。
- 后续神经及全身分期确认淋巴瘤为局限性疾病。
- 患者接受局部放疗以控制软脑膜病变。
临床怎么用
- 作者建议(原文用 suggest)结节病患者硬脑膜占位应将淋巴瘤列为重要鉴别诊断之一。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Primary dural-based lymphoma is a rare disease entity. It has been hypothesized that patients with sarcoidosis are at increased risk of developing lymphoma, an association known as "sarcoidosis-lymphoma syndrome," although dural disease has not yet been reported in the literature. CASE DESCRIPTION: Here we report the first case of dural-based lymphoma in a 60-year-old man with a history of sarcoidosis, in keeping with sarcoidosis-lymphoma syndrome. His dural-based tumor was surgically resected. Pathology examination revealed a marginal zone B-cell lymphoma. Subsequent neural and systemic staging confirmed a localized lymphoma. The patient received local radiotherapy to control leptomeningeal disease. CONCLUSIONS: Given the association between sarcoidosis and lymphoma, we suggest lymphoma to be considered as one of the top differentials for a dural-based mass lesion in patients with sarcoidosis.
引用
- Yang K, Algird AR, Lu JQ, et al. Dural-Based Marginal Zone Lymphoma in a Patient with Sarcoidosis. World Neurosurg. 2018. PMID: 30476667. doi:10.1016/j.wneu.2018.11.125
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。